Dr. Nancy Davidson is Executive Vice President and Chief Academic Officer at Fred Hutch, where she helps unite the cancer treatment and research programs of the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium. An internationally recognized breast cancer oncologist, she has built a reputation for uncovering how hormones drive breast cancer growth and for shaping new standards of care. Her research clarified how estrogen receptors are regulated and how estrogen deprivation therapies trigger cancer cell death, paving the way for clinical trials that transformed treatment. In addition to leading pivotal studies that defined modern therapeutic regimens, she is widely regarded as a leader who bridges scientific discovery with patient care.
Dr. Mary (Nora) Disis is a nationally recognized leader in cancer immunotherapy and the Director of the Cancer Vaccine Institute at the University of Washington. A pioneer in the field, her research focuses on developing vaccines and T-cell therapies for breast, ovarian, and colon cancers. Her work has led to clinical trials targeting HER-2/neu and other tumor antigens. Dr. Disis has received four research grants from the American Cancer Society, including her most recent to develop a multi-antigen vaccine aimed at preventing colon cancer. In addition to serving as Associate Dean for Translational Science at the UW School of Medicine, she is the Editor in Chief of JAMA Oncology and holds the Helen B. Slonaker Endowed Professorship for Cancer Research.
Osman represents the 48th Legislative District, including parts of Bellevue, Redmond, Kirkland, and all of Clyde Hill, Medina, Yarrow Point, and Hunts Point. A Redmond native and proud son of immigrants—a special education teacher and small business owner—he earned a B.S. in neurobiology from the University of Washington, where he served as Student Body President. Before being elected, Osman worked as a researcher at Fred Hutch Cancer Research Center and UW Medicine. He has served his community on the Redmond City Council, worked for the King County Council, and contributed to non-profit boards like the Transportation Choices Coalition.
Joseph serves as Deputy Director at CARE Fund, where his areas of responsibility including communications, external relationships and partnering with the Executive Director of strategy and partnerships.
Joseph brings 25+ years of experience in non-profit leadership, capacity building, strategy and external relations, with a background in community-based health. Prior to joining CARE Fund, Joseph worked with Neighborcare Health as Chief Development Officer, and as an independent consultant with multiple non-profits focused on equity in healthcare, serving residents of Washington.
Linda Penwarden is an Oncology Clinical Nurse Specialist with over 38 years of clinical practice experience. Predominately practicing at St. Luke’s Mountain States Tumor Institute in Boise, ID, Linda is known for her commitment to excellent patient care and for furthering the oncology nursing community activities through research, publishing, and presentations. She returned to her home town of Sequim in 2022, and is attempting to retire yet continues to volunteer for the American Cancer Society, Oncology Nursing Society, Volunteer Hospice of Clallam County, and other non-profit organizations.
Biography coming soon.
Luisa Calad is a passionate advocate for cancer prevention and early detection, inspired by the memory of her mother, who passed away from ovarian cancer at the age of 44. At just 40 years old, Luisa tested positive for the BRCA-1 gene mutation, a discovery that led her to undergo preventive surgeries, including a mastectomy and oophorectomy.
Through her journey, both as a daughter who witnessed her mother’s fight and as a survivor who chose life through prevention, Luisa has become a voice of hope and resilience. She believes deeply in the power of research, compassion, and community, what she calls a “chain of love” — to carry us through the hardest battles.
Today, Luisa shares her story to inspire others to take action, support lifesaving research, and ensure that no one faces cancer alone.